Mdm2-dependent ubiquitination and degradation of the insulin-like growth factor 1 receptor.
about
Molecular basis of signaling specificity of insulin and IGF receptors: neglected corners and recent advances{beta}-Arrestin is crucial for ubiquitination and down-regulation of the insulin-like growth factor-1 receptor by acting as adaptor for the MDM2 E3 ligaseMdm2 is involved in the ubiquitination and degradation of G-protein-coupled receptor kinase 2Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptorUpregulation of the E3 ligase NEDD4-1 by oxidative stress degrades IGF-1 receptor protein in neurodegenerationDownregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma developmentNedd4 controls animal growth by regulating IGF-1 signalingNedd4 and Nedd4-2: closely related ubiquitin-protein ligases with distinct physiological functionsInsulin-like Growth Factor 1 Signaling Axis Meets p53 Genome Protection PathwaysThe insulin-like growth factor system in multiple myeloma: diagnostic and therapeutic potentialTriad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptorsTwo strategies for the development of mitochondrion-targeted small molecule radiation damage mitigatorsInsulin-like growth factor 1 receptor is a prognostic factor in classical Hodgkin lymphoma.Role of ubiquitination in IGF-1 receptor signaling and degradation.MDM2 promotes proteasomal degradation of p21Waf1 via a conformation change.Inhibition of TFII-I-dependent cell cycle regulation by p53.Something old, something new and something borrowed: emerging paradigm of insulin-like growth factor type 1 receptor (IGF-1R) signaling regulationAntitumor effects and molecular mechanisms of figitumumab, a humanized monoclonal antibody to IGF-1 receptor, in esophageal carcinoma.Ligand-mediated endocytosis and trafficking of the insulin-like growth factor receptor I and insulin receptor modulate receptor function.Screening E3 substrates using a live phage display libraryThe association of TP53 mutations with the resistance of colorectal carcinoma to the insulin-like growth factor-1 receptor inhibitor picropodophyllin.MDM2 promotes cell motility and invasiveness by regulating E-cadherin degradation.OVA66 increases cell growth, invasion and survival via regulation of IGF-1R-MAPK signaling in human cancer cells.Role of IGF1R in Breast Cancer Subtypes, Stemness, and Lineage DifferentiationPre-apoptotic response to therapeutic DNA damage involves protein modulation of Mcl-1, Hdm2 and Flt3 in acute myeloid leukemia cells.Selective recruitment of G protein-coupled receptor kinases (GRKs) controls signaling of the insulin-like growth factor 1 receptor.Role of insulin-like growth factor 1 receptor signalling in cancer.The Regulation of Multiple p53 Stress Responses is Mediated through MDM2Lymphokine-activated killer T-cell-originated protein kinase phosphorylation of histone H2AX prevents arsenite-induced apoptosis in RPMI7951 melanoma cells.β-Arrestin-biased agonism as the central mechanism of action for insulin-like growth factor 1 receptor-targeting antibodies in Ewing's sarcoma.Cathepsin Inhibition Prevents Autophagic Protein Turnover and Downregulates Insulin Growth Factor-1 Receptor-Mediated Signaling in NeuroblastomaDNA damage is a prerequisite for p53-mediated proteasomal degradation of HIF-1alpha in hypoxic cells and downregulation of the hypoxia marker carbonic anhydrase IX.IGF-1 receptor is down-regulated by sunitinib induces MDM2-dependent ubiquitination.MDM2 E3 ubiquitin ligase mediates UT-A1 urea transporter ubiquitination and degradation.The ubiquitin ligase Nedd4 mediates oxidized low-density lipoprotein-induced downregulation of insulin-like growth factor-1 receptorProfiling of ubiquitin-like modifications reveals features of mitotic control.Role of IGF1R(+) MSCs in modulating neuroplasticity via CXCR4 cross-interaction.Crosstalk between the IGF-1R/AKT/mTORC1 pathway and the tumor suppressors p53 and p27 determines cisplatin sensitivity and limits the effectiveness of an IGF-1R pathway inhibitor.Degradation of activated protein kinases by ubiquitination.Building the Case for Insulin-Like Growth Factor Receptor-I Involvement in Thyroid-Associated Ophthalmopathy.
P2860
Q21131281-B18B940B-DDA9-44EF-8FEC-A43E534716E7Q24301549-D4E65A03-BFA3-40BF-96B1-B3CA6AD4B952Q24305064-0C951567-EE03-41FD-A5DE-1D5A682F27B7Q24306866-B1170817-6ED8-4690-8992-B945A26BA3B0Q24613053-ACACF0AD-F07D-4617-9D24-AFEA57E1D9D2Q24628811-246469D6-0C34-48A5-87F3-082DAC4A672EQ24632761-E93C7582-7E67-4D32-BD40-20A3EDD20AC3Q24651528-76CA15C5-AF05-456E-A670-042E1330B358Q26742114-20BFEB5E-B819-44FF-A973-B745AF366973Q28075927-83FD9EBC-70BF-4BB5-A8FB-26B106A15557Q28258400-0DA9E297-69E4-4E45-BE32-1245740B6D78Q28388871-D12DBDD5-C5CA-4CD5-A260-49493C4306F7Q31149390-3F626DC4-C577-4DF9-9FC3-75518D03ADBBQ33280993-7D8380BE-10B4-403A-A758-B16F2058F8CAQ33897779-35E75199-B6FC-41A2-ABCB-7EDE4C4B5A04Q34230848-7D2F4E21-D4AF-48CB-B176-D0C2A1EB275AQ34387886-048ED0BD-9C5A-4C68-B80F-691482DDF1C6Q34431333-4E770695-6DBE-4755-8CE1-CCBB747BBE7CQ34722516-98F9084D-3163-4014-A443-FB38620EBA5DQ35017038-7920119B-F530-4E4E-86C9-42726ED48585Q35030616-95A860E4-18CE-4D1F-B8F6-5C61ACCD0C91Q35071303-874DA9FE-378F-40A1-AA6A-33E6B7954EB0Q35131269-F4513FFD-E6E0-4EAE-BBD9-DD7F29F2AFECQ35535296-4DEDBCCC-2959-472F-AC37-1B61FDCF8A5DQ35808597-D65D243B-AFFF-4DB9-87E8-2FA455B4A773Q35935789-DD3AA6EE-FBFC-42BA-B5E0-70269A577390Q36163571-52BA2EC1-0B60-489D-8669-E3DA3E2AECCFQ36387610-DAB5C642-12DF-4D04-8168-B9924A752952Q36453943-02D5D451-4449-4141-80CA-AF1D052A1AB1Q36483910-E76177D5-8FD2-4AE0-A7EA-EC993895020DQ36559668-1DA18352-3923-4464-9F90-08FDBACA8B8AQ36732878-60FF294A-45D7-4FDF-BE91-C2D737EEB726Q36811817-256008A4-A7A1-4E8A-9998-D5A0A1DE0CB4Q36977443-C07F4990-975D-47F1-BF77-B536710515DBQ36995166-A9713BD5-6AB0-45AC-84E2-F732CC867E63Q37011725-58A5FA2E-5E2B-4390-AE4F-481F8264467FQ37227786-6C9B4807-4904-4272-B9B9-E34DD160D60BQ37317313-CFB8CE7F-0399-4FF0-95C4-0B6E5813CAEEQ37419861-90AB0C94-D58C-4D93-97B1-9019C95F494DQ37550127-AC5A14B8-7181-4083-A206-FA4B57476A94
P2860
Mdm2-dependent ubiquitination and degradation of the insulin-like growth factor 1 receptor.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Mdm2-dependent ubiquitination ...... like growth factor 1 receptor.
@ast
Mdm2-dependent ubiquitination ...... like growth factor 1 receptor.
@en
type
label
Mdm2-dependent ubiquitination ...... like growth factor 1 receptor.
@ast
Mdm2-dependent ubiquitination ...... like growth factor 1 receptor.
@en
prefLabel
Mdm2-dependent ubiquitination ...... like growth factor 1 receptor.
@ast
Mdm2-dependent ubiquitination ...... like growth factor 1 receptor.
@en
P2093
P2860
P356
P1476
Mdm2-dependent ubiquitination ...... like growth factor 1 receptor.
@en
P2093
Ada Girnita
Leonard Girnita
Olle Larsson
P2860
P304
P356
10.1073/PNAS.1431613100
P407
P577
2003-06-23T00:00:00Z